z-logo
Premium
Home and hospital intravenous therapy for two acute infections: an early study
Author(s) -
Montalto M.,
Dunt D.
Publication year - 1997
Publication title -
australian and new zealand journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 0004-8291
DOI - 10.1111/j.1445-5994.1997.tb00908.x
Subject(s) - medicine , intravenous antibiotics , antibiotics , microbiology and biotechnology , biology
Aim : To study the severity, treatment and outcome of patients with cellulitis and pyelonephritis treated with intravenous antibiotics in either a hospital in the home unit (HHU) or traditional inpatient beds. Method: Retrospective case reviews were used. All patients with cellulitis and pyelonephritis from January 1995 until January 1996 who were assessed as appropriate for HHU care were included. Each HHU case was included. The traditional in‐hospital group was defined as patients who had been assessed as suitable for HHU, but who did not enter the HHU for non‐clinical reasons. Background variables were: patient age; patient gender; prior treatment with antibiotics; temperature on presentation; creatinine on presentation; leucocyte count on presentation; parenteral medication used; and pre‐existent conditions. Outcome variables were: number of days until febrifuge; total duration of stay; duration of in‐hospital stay; duration of HHU stay; patient incidents; and status at discharge. Results: The two groups exhibited similarities on patient and condition characteristics, although differences in the types of antibiotics used were found. A positive clinical outcome was achieved in every patient. In‐hospital duration of stay was briefer in the HHU groups. Discussion: These early results are encouraging for home intravenous therapy. Further studies, controlled trials if possible, are now required to establish these findings more definitively.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here